Literature DB >> 1559007

Serological and biochemical properties of Shiga-like toxin (verocytotoxin)-producing strains of Escherichia coli, other than O-group 157, from patients in Germany.

J Bockemühl1, S Aleksić, H Karch.   

Abstract

During 1987-1990, 62 infections with Shiga-like toxin (Verocytotoxin)-producing E. coli, other than O group 157, were identified. The isolates belonged to 26 serovars within 20 O groups; of them, 10 serovars belonged to 6 O groups of traditional enteropathogenic E. coli (EPEC). The serovars O2:H5 and O91:H14 were exclusively associated with ulcerative colitis. Eighteen patients (children under 4 years of age) developed a haemolytic uraemic syndrome. All together, 31 strains produced SLT I, 26 strains, SLT II, and 5 strains, both toxins. All strains produced beta-glucuronidase and fermented, with one exception, D-sorbitol. The phenotypic diversity of SLT-producing E. coli implies that the only means of their identification is by indirect (genetic) or direct (phenotypic) demonstration of toxin production.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1559007     DOI: 10.1016/s0934-8840(11)80005-8

Source DB:  PubMed          Journal:  Zentralbl Bakteriol        ISSN: 0934-8840


  20 in total

1.  Molecular characteristics and epidemiological significance of Shiga toxin-producing Escherichia coli O26 strains.

Authors:  W L Zhang; M Bielaszewska; A Liesegang; H Tschäpe; H Schmidt; M Bitzan; H Karch
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Virulence of the Shiga toxin type 2-expressing Escherichia coli O104:H4 German outbreak isolate in two animal models.

Authors:  Tonia Zangari; Angela R Melton-Celsa; Aruna Panda; Nadia Boisen; Mark A Smith; Ivan Tatarov; Louis J De Tolla; James P Nataro; Alison D O'Brien
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

3.  Prevalence and clinical manifestations of Shiga toxin-producing Escherichia coli infections in Austrian children.

Authors:  F Allerberger; D Rossboth; M P Dierich; S Aleksic; H Schmidt; H Karch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-07       Impact factor: 3.267

4.  A genomic island, termed high-pathogenicity island, is present in certain non-O157 Shiga toxin-producing Escherichia coli clonal lineages.

Authors:  H Karch; S Schubert; D Zhang; W Zhang; H Schmidt; T Olschläger; J Hacker
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  Differences in verotoxin neutralizing activity of therapeutic immunoglobulins and sera from healthy controls.

Authors:  M Bitzan; M Klemt; R Steffens; D E Müller-Wiefel
Journal:  Infection       Date:  1993 May-Jun       Impact factor: 3.553

6.  Genetic analysis for virulence factors in Escherichia coli O104:H21 that was implicated in an outbreak of hemorrhagic colitis.

Authors:  P Feng; S D Weagant; S R Monday
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

7.  Murine monoclonal antibodies against Escherichia coli O4 lipopolysaccharide and H5 flagellin.

Authors:  M Rivera-Betancourt; J E Keen
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

8.  Prevalence and some properties of verotoxin (Shiga-like toxin)-producing Escherichia coli in seven different species of healthy domestic animals.

Authors:  L Beutin; D Geier; H Steinrück; S Zimmermann; F Scheutz
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

9.  Differentiation in virulence patterns of Escherichia coli possessing eae genes.

Authors:  H Schmidt; B Plaschke; S Franke; H Rüssmann; A Schwarzkopf; J Heesemann; H Karch
Journal:  Med Microbiol Immunol       Date:  1994-02       Impact factor: 3.402

10.  Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model.

Authors:  S W Lindgren; A R Melton; A D O'Brien
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.